These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19738013)

  • 1. In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5317-8. PubMed ID: 19738013
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of the new quinolone derivative RD-3 against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.
    Sainath Rao S; Raghunathan M
    J Antimicrob Chemother; 2009 Dec; 64(6):1336-8. PubMed ID: 19850565
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Xue G; Crabb DM; Xiao L; Liu Y; Waites KB
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
    Cohen MA; Huband MD
    J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmas.
    Waites KB; Reddy NB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2541-2. PubMed ID: 15917568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.
    Waites KB; Crabb DM; Liu Y; Duffy LB
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7502-7504. PubMed ID: 27671057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.
    Gruson D; Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1190-3. PubMed ID: 15728924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.
    Pereyre S; de Barbeyrac B; Renaudin H; Poutiers F; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2001 Feb; 47(2):240-1. PubMed ID: 11157917
    [No Abstract]   [Full Text] [Related]  

  • 10. Bactericidal activity of levofloxacin against Mycoplasma pneumoniae.
    Duffy LB; Crabb DM; Bing X; Waites KB
    J Antimicrob Chemother; 2003 Sep; 52(3):527-8. PubMed ID: 12888583
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Waites KB; Crabb DM; Xiao L; Duffy LB
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3776-8. PubMed ID: 18663020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.
    Waites KB; Duffy LB; Bébéar CM; Matlow A; Talkington DF; Kenny GE; Totten PA; Bade DJ; Zheng X; Davidson MK; Shortridge VD; Watts JL; Brown SD
    J Clin Microbiol; 2012 Nov; 50(11):3542-7. PubMed ID: 22915608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.
    Xin D; Mi Z; Han X; Qin L; Li J; Wei T; Chen X; Ma S; Hou A; Li G; Shi D
    Antimicrob Agents Chemother; 2009 May; 53(5):2158-9. PubMed ID: 19273685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
    Morozumi M; Iwata S; Hasegawa K; Chiba N; Takayanagi R; Matsubara K; Nakayama E; Sunakawa K; Ubukata K;
    Antimicrob Agents Chemother; 2008 Jan; 52(1):348-50. PubMed ID: 17954691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
    Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
    Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae.
    Dégrange S; Renaudin H; Charron A; Pereyre S; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2008 Jun; 61(6):1390-2. PubMed ID: 18356155
    [No Abstract]   [Full Text] [Related]  

  • 19. Turning the Tide against Antibiotic Resistance by Evaluating Novel, Halogenated Phenazine, Quinoline, and NH125 Compounds against
    Valentine-King MA; Cisneros K; James MO; Huigens RW; Brown MB
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis on antibacterial activity of common antibiotics to Mycoplasma pneumoniae].
    Xin DL; Chen XG; Han X
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):305-6. PubMed ID: 19555573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.